4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-010833
10% owner sold 22,841 shares at an average $50.99 ($1,164,655)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital V, L.P. 10% owner | 2018-04-24 | Sale | −20,071 | $51.00 | $1,023,621 | 1,519,505 | I |
| Versant Venture Capital V, L.P. 10% owner | 2018-04-24 | Sale | −589 | $50.60 | $29,803 | 44,582 | I |
| Versant Venture Capital V, L.P. 10% owner | 2018-04-24 | Sale | −653 | $51.00 | $33,303 | 49,419 | I |
| Versant Venture Capital V, L.P. 10% owner | 2018-04-24 | Sale | −1,528 | $51.00 | $77,928 | 115,645 | I |
| Open-market sales · 22,841 sh · avg $50.99 · $1,164,655 | |||||||
Loading xslF345X03/doc4.xml…